Finding 509340 (2023-004)

Significant Deficiency
Requirement
AB
Questioned Costs
-
Year
2023
Accepted
2024-11-20
Audit: 329124
Organization: Hiv Alliance INC (OR)
Auditor: Isler CPA LLC

AI Summary

  • Core Issue: Internal controls for reviewing and approving non-payroll costs were ineffective, leading to missing documentation for some expenses.
  • Impacted Requirements: Compliance with Title 2 U.S. Code of Federal Regulations 200.303, which mandates robust internal controls for federal grant expenditures.
  • Recommended Follow-up: Strengthen processes to ensure all internal control documentation is complete and accessible for future audits.

Finding Text

2023-004 Substance Abuse Prevention and Treatment Block Grant - Assistance Listing No. 93.959; Oregon Health Authority Subgrant No. 167552; Grant period - Year ended June 30, 2023. Compliance Requirements: Allowable Activities and Allowable Costs Criteria and Condition: Title 2 U.S. Code of Federal Regulations 200.303 Internal Controls requires grantees to establish and maintain internal controls sufficient to provide reasonable assurance of compliance with applicable statutes, regulations, and terms and conditions of Federal awards. Internal controls related to the review and approval of non-payroll costs were not operating effectively throughout the grant period. Context: Twenty-five non-payroll expenses were selected for testing. The invoice for one of the selected items could not be located; as such, no evidence was available to demonstrate the operation of review and approval controls. The provided invoice and support for two additional items selected for testing did not show evidence of being reviewed. The three items were not determined to be instances of noncompliance as the information avaliabe was sufficient to demonstrate compliance with allowable activity and allowable cost requirements. Cause: Processes and procedures were not sufficient to ensure that evidence of the performance of internal controls was readily available for all grant expenditures. Effect: If not reviewed and approved according to HIV Alliance's policies, unallowable activities and costs could be funded with federal awards and result in instances of noncompliance. Recommendation: Processes and procedures should be reviewed and strengthened to ensure all controls are appropriately documented and available for review by internal and external parties at a later date. Management's Response: Processes will be implemented and monitored to ensure all expenses include evidence of the review and approval procedures performed.

Corrective Action Plan

Finding 2023-04- Allowable Activities and Allowable Costs All HIV Alliance expense transactions and journal entries will be entered by one member of the finance team and reviewed to verify accuracy and to verify that the appropriate documents and approvals are attached in FE by a second staff member.

Categories

Allowable Costs / Cost Principles

Other Findings in this Audit

  • 509338 2023-002
    Material Weakness
  • 509339 2023-003
    Significant Deficiency
  • 1085780 2023-002
    Material Weakness
  • 1085781 2023-003
    Significant Deficiency
  • 1085782 2023-004
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.959 Block Grants for Prevention and Treatment of Substance Abuse $710,355
93.939 Hiv Prevention Activities Non-Governmental Organization Based $466,582
93.928 Special Projects of National Significance $154,177
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $149,374
93.788 Opioid Str $116,475
93.940 Hiv Prevention Activities Health Department Based $99,981
14.218 Community Development Block Grants/entitlement Grants $86,290
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $65,458
14.231 Emergency Solutions Grant Program $15,313
97.024 Emergency Food and Shelter National Board Program $7,428
93.350 National Center for Advancing Translational Sciences $4,157
93.279 Drug Abuse and Addiction Research Programs $485
93.917 Hiv Care Formula Grants $1